Dr. Davide Pinnavaia graduated in Chemistry and Pharmaceutical Technology from the University of Turin in 2021 and is attending the School of Hospital Pharmacy at the same university.
Since 2021 he has worked at IRCCS Candiolo in the Hospital Pharmacy service; since 2024 he has been a Pharmacist Executive. He serves in the Antiblastic Drugs Unit and on the management staff of many clinical trials; he is among the referring pharmacists for phase I studies.
He has presented several papers in the form of posters at national congresses.